| Size | Price | Stock | Qty |
|---|---|---|---|
| 5mg |
|
||
| 10mg |
|
||
| Other Sizes |
| Targets |
No specific biological target. Sulfo DBCO-PEG4-Maleimide TEA is a bioconjugation reagent. The DBCO group reacts with azides via copper-free click chemistry (SPAAC), while the maleimide group reacts specifically with sulfhydryl groups (thiols, typically from cysteine residues). The PEG4 spacer improves water solubility and reduces non-specific interactions.
|
|---|---|
| ln Vitro |
Not applicable. Sulfo DBCO-PEG4-Maleimide TEA is a chemical linker used for the conjugation of biomolecules. It is not used as a modulator of biological activity but rather as a tool for generating labeled antibodies, proteins, or PROTAC degraders. The reactivity of both functional groups is maintained under mild, aqueous conditions.
|
| ln Vivo |
Not applicable. Sulfo DBCO-PEG4-Maleimide TEA is not used as a therapeutic agent. It is used in the synthesis of PROTACs (proteolysis-targeting chimeras) and antibody-drug conjugates (ADCs). When incorporated into these molecules, it can contribute to in vivo efficacy by facilitating targeted protein degradation or tumor cell killing.
|
| Enzyme Assay |
Non-cell-based conjugation assay: A thiol-containing protein (1 mg/mL in PBS, pH 7.4) is incubated with sulfo DBCO-PEG4-maleimide TEA (2-20 equivalents) for 2 h at room temperature. The maleimide-thiol reaction efficiency is assessed by mass spectrometry or SDS-PAGE. DBCO-azide click conjugation efficiency is assessed by incubating the maleimide-labeled protein with an azide-containing fluorophore for 1-4 h and measuring fluorescence.
|
| Cell Assay |
Cell surface conjugation: Cells expressing azide-labeled surface glycans (via metabolic labeling with azido-sugars) are incubated with sulfo DBCO-PEG4-maleimide TEA (10-100 uM) for 30-60 min at 37degC. After washing, cells are fixed and analyzed by flow cytometry or confocal microscopy. The maleimide group can be used to attach thiol-functionalized cargoes.
|
| Animal Protocol |
Not applicable as an independent drug. Sulfo DBCO-PEG4-Maleimide TEA is used for the ex vivo labeling of cells or for the preparation of conjugates that are subsequently administered in animal models. For example, a thiol-containing antibody is conjugated to an azide-containing payload via this reagent, and the resulting conjugate is injected into mice for pharmacokinetic or efficacy studies.
|
| ADME/Pharmacokinetics |
Pharmacokinetic data for Sulfo DBCO-PEG4-Maleimide TEA alone are not relevant. As a PEG-containing reagent (MW 927.07), it is designed to improve the aqueous solubility and pharmacokinetic properties of the conjugates it creates. The PEG4 spacer reduces immunogenicity and increases circulating half-life when attached to proteins. The compound should be stored at -20degC, sealed, away from moisture.
|
| Toxicity/Toxicokinetics |
Toxicity data for Sulfo DBCO-PEG4-Maleimide TEA are not reported, as it is a chemical linker for research use only. It should be handled with care to avoid inhalation, ingestion, and skin contact. Maleimide reagents can be skin irritants and may cause allergic reactions. The compound is not approved for human therapeutic or diagnostic use.
|
| References |
[1]. An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
|
| Additional Infomation |
Sulfo DBCO-PEG4-Maleimide TEA is a research-grade click chemistry linker for bioconjugation, PROTAC synthesis, and ADC development. It is not a drug and has no therapeutic indications. The DBCO group enables copper-free click chemistry, which is desirable for live-cell and in vivo labeling. The TEA salt improves stability. For research use only.
|
| Molecular Formula |
C45H62N6O13S
|
|---|---|
| Related CAS # |
Sulfo DBCO-PEG4-Maleimide;2055198-07-5
|
| Appearance |
Light yellow to yellow oil
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
|
|---|---|
| Solubility (In Vivo) |
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.
Injection Formulations
Injection Formulation 1: DMSO : Tween 80： Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)(e.g. IP/IV/IM/SC) *Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution. Injection Formulation 2: DMSO : PEG300 ：Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil) Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals). View More
Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)] Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium) Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals). View More
Oral Formulation 3: Dissolved in PEG400 (Please use freshly prepared in vivo formulations for optimal results.) |
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
